SEC Filing Summary: Prestige Brands Holdings, Inc.
Business Context and Reporting Period
This Form 8-K was filed on October 11, 2007, by Prestige Brands Holdings, Inc. (the "Registrant"). The filing serves as a Regulation FD disclosure regarding a voluntary product recall.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory disclosure event rather than financial performance data.
Material Changes and Events
The primary material event reported is the voluntary recall of two Little Colds® products. These products are Over-the-Counter Oral Infant Cough and Cold medicated products. The recall was initiated in coordination with other providers of similar products.
Management Commentary and Risks
- Management Action: The company announced the recall via a press release attached as Exhibit 99.1.
- Legal Status: The information in this Form 8-K and the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 unless specifically stated otherwise by the Registrant.
- Risks: The recall implies potential product safety concerns or regulatory compliance issues affecting the infant cough and cold product line.
Investor Verification Checklist
- Verify the specific lot numbers and distribution scope of the recalled Little Colds® products.
- Review the attached press release (Exhibit 99.1) for details on the reason for the recall and any reported adverse health effects.
- Monitor subsequent filings for updates on the recall's financial impact, including potential litigation or restocking costs.
- Confirm if the recall affects other product lines beyond the two specified infant cough and cold products.